Immunophenotypic analysis with enhanced sensitivity of detection by enzymatic amplification staining

Clinics in Laboratory Medicine

Volumn 21, Issue 4, 2001, Pages 763-778

  Kaplan, D ^a   Husel, W ^a   Meyerson, H ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPHYCOCYANIN; CD2 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD79B ANTIGEN; CELL ANTIGEN; CELL PROTEIN; CELL SURFACE PROTEIN; CHLOROPHYLL; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; DNA; FLUORESCEIN ISOTHIOCYANATE; GEMTUZUMAB OZOGAMICIN; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR; MICROSOMAL AMINOPEPTIDASE; PHYCOERYTHRIN; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; DNA CONTENT; ENZYMATIC AMPLIFICATION STAINING; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MEMBRANE PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 0035209942     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Comparison of poly- and monoclonal antibodies for determination of B-cell clonal excess in a routine clinical laboratory
2. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles
3. Leu-1+ (CD5+) B cells: A major lymphoid subpopulation in human fetal spleen: Phenotypic functional studies
4. The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation
5. Localization of monoclonal B-cell populations through the use of Komogorov-Smirnov D-value and reduced chi-square contours
6. CD10 expression in follicular lymphoma versus reactive follicular hyperplasia: Evaluation in paraffin-embedded tissue
7. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells
8. Immunophenotypic identification of Sezary cells in peripheral blood
9. Differential expression of chemokine receptors and chemotactic responsiveness of type I helper cells (Th1s) and Th2s
10. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders
11. B-chronic lymphocytic leukemia: A malignancy of anti-self B cells
12. CD5 negative B-cell chronic lymphocytic leukemia: Clinical and biological features of 42 cases
13. Adult and childhood acute lymphoblastic leukemia: Clinico-biological differences based on CD34 antigen expression
14. Are "early" and "late" T-acute lymphoblastic leukemias different diseases? A single center study of 34 patients
15. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: Different sensitivity to inhibition between systemic sclerosis and control fibroblasts
16. Enumeration of CR1 complement receptors on erythrocytes using a new method for detecting low density cell surface antigens by flow cytometry
17. A comparison of the sensitivity of immunoperoxidase staining methods with high-sensitivity fluorescence flow cytometry-antibody quantitation on the cell surface
18. Comparison of frequency distributions in flow cytometry
19. Discordance of P-glycoprotein expression and function in acute leukemia
20. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia
21. P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukemia: Results of a 6-year prospective study
22. Clinical utility of flow cytometry in the chronic lymphoid leukemias
23. Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: Increased concentration of CD33 antigen predicts poor outcome - A report from the Childrens Cancer Study Group
24. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas
25. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma
26. Identification of acute myeloid leukemia patients with diminished expression of CD13 myeloid transcripts by competitive reverse transcription polymerase chain reaction (RT-PCR)
27. Diminished CD3 expression is useful for detecting and enumerating Sezary cells
28. Drug resistance factors in acute myeloid leukemia: A comparative analysis
29. Differential expression of CD3 and CD7 in T-cell malignancies: A quantitative study by flow cytometry
30. Introduction: Focus on hematology. CD34(+) or CD34(-): Does it really matter?
31. Dye efflux studies suggest the existence of CD34-negative/low hematopoietic stem cells in multiple species
32. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells
33. Signal enhancement in fluorescence microscopy and flow cytometry using fluorescent liposome-antibody conjugates as second layer reagents
34. Distinctive developmental origins and specificities of the CD5+ B-cell subset
35. Aberrant phenotypes in peripheral T cell lymphomas
36. Crossmatching for renal transplantation - A 5-year review of different cytotoxic and flow cytometric methods showing importance of the IgG anti-B-lymphocyte FACS crossmatch
37. CD5-small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia
38. Enzymatic amplification staining for flow cytometric analysis of cell surface molecules
39. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma
40. On the use of the Kolmogorov-Smirnov statistical test for immunofluorescence histogram comparison
41. Detection of low numbers of lymphocyte surface membrane molecules using concentration immunofluorescence analysis (CIA)
42. An improved clonal excess assay using flow cytometry and B-cell gating
43. CD5 B cells and B-cell malignancies
44. Kinetics of CXCR4 and CCR5 upregulation and human immunodeficiency virus expansion after antigenic stimulation of primary CD4(+) T lymphocytes
45. Measuring multidrug resistance expression in human malignancies: Elaboration of consensus recommendations
46. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders
47. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia
48. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)
49. Biology of the interleukin-2 receptor
50. Enhanced myeloid specificity of CD117 compared with CD13 and CD33
51. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell
52. CD20+ T-cell lymphoma. Neoplastic transformation of a normal subset
53. Direct contact between T lymphocytes and human dermal fibroblasts or synoviocytes down-regulates types I and III collagen production via cell-associated cytokines
54. High-sensitivity immunofluorescence for detection of the pro- and anti-inflammatory cytokines gamma interferon and interleukin-10 on the surface of cytokine-secreting cells
55. Magnetofluorescent liposomes for increased sensitivity of immunofluorescence
56. Techniques to improve flow cytometric detection of light chain restriction
57. Selective ablation of acute myelogenous leukemia using antibody-targeted chemotherapy: A phase I study of an anti-CD33 calicheamicin immunoconjugate
58. Comparative analysis of class I, II, and III epitopedetecting CD34 monoclonal antibodies by quantitative flow cytometry
59. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia
60. Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia
61. Detection of very low receptor numbers on cells by flow cytometry using a sensitive staining method
62. Antibody-bearing liposomes as multicolor immunofluorescence markers for flow cytometry and imaging
63. Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma
64. The use of antibodies against the IL-2 receptor in transplantation
65. Molecular calibration in flow cytometry with sub-attograms detection limit
66. Cytotoxic flow-cytometric crossmatches (flow-tox): A comparison with conventional cytotoxicity crossmatch techniques
67. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: Studies of the Southwest Oncology Group Research Program
68. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells
69. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: A clinicopathologic comparison of cyclin D1positive MCL and cyclin D1-negative MCL-like B-cell lymphoma
70. CD5 expression in human B-cell populations
71. Detection of receptors for cytokines and growth factors
72. Expression of cytokine receptors by human cord blood lymphocytes: Comparison with adult blood lymphocytes
73. Detection by immunofluorescence of surface molecules present in low copy numbers: High sensitivity staining and calibration of flow cytometer
74. Expression of the p70 chain of the IL-2 receptor on human lymphoid cells: Analysis using a monoclonal antibody and high-sensitivity immunofluorescence